New insider activity at Incyte ( (INCY) ) has taken place on July 23, 2025.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
EVP & Chief Medical Officer Steven H Stein recently sold 3,706 shares of Incyte stock, amounting to a total transaction value of $251,785.
Spark’s Take on INCY Stock
According to Spark, TipRanks’ AI Analyst, INCY is a Outperform.
Incyte’s overall stock score reflects its solid financial position and strong earnings call performance. The company’s robust revenue growth and strategic initiatives are significant strengths. However, high valuation metrics and potential competition pose risks. Recent corporate events provide operational flexibility but also immediate financial impacts.
To see Spark’s full report on INCY stock, click here.
More about Incyte
YTD Price Performance: -0.91%
Average Trading Volume: 1,850,564
Technical Sentiment Signal: Buy
Current Market Cap: $13.34B